Literature DB >> 3711372

L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine.

R Sandyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3711372     DOI： 10.1097/00004714-198606000-00022

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

2.  Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.

Authors:  D Lindenbach; N Palumbo; C Y Ostock; N Vilceus; M M Conti; C Bishop
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 3.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

4.  Serotonin syndrome following levodopa treatment in diffuse Lewy body disease.

Authors:  Suman Kushwaha; Akhila Kumar Panda; Hardeep Singh Malhotra; Manmeet Kaur
Journal:  BMJ Case Rep       Date:  2014-09-22

Review 5.  Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.

Authors:  E H Heinonen; V Myllylä
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.